Current diagnostic biomarkers for ACS are mainly represented by troponin I and troponin T. Dosing of these two molecules often leads to false positive results, since their plasma levels can increase in several different systemic settings. Therefore, identification of new markers able to detect patients with acute coronary syndromes is an emerging priority. On this view, many studies have been performed on different microRNAs, mitochondrial peptides, inflammatory cytokines and adhesion molecules with very promising results. Besides their introduction in screening programs, further studies are now needed in the acute setting, beyond or in association with troponin levels. This will help to better discriminate the real occurrence of an ACS in many patients accessing the emergency department for chest pain.

Piccioni, A., Valletta, F., Zanza, C., Esperide, A., Franceschi, F., Novel biomarkers to assess the risk for acute coronary syndrome: beyond troponins, <<INTERNAL AND EMERGENCY MEDICINE>>, 2020; 15 (7): 1193-1199. [doi:10.1007/s11739-020-02422-z] [https://hdl.handle.net/10807/231889]

Novel biomarkers to assess the risk for acute coronary syndrome: beyond troponins

Piccioni, Andrea;Valletta, Federico;Zanza, Christian;Esperide, Alessandra;Franceschi, Francesco
2020

Abstract

Current diagnostic biomarkers for ACS are mainly represented by troponin I and troponin T. Dosing of these two molecules often leads to false positive results, since their plasma levels can increase in several different systemic settings. Therefore, identification of new markers able to detect patients with acute coronary syndromes is an emerging priority. On this view, many studies have been performed on different microRNAs, mitochondrial peptides, inflammatory cytokines and adhesion molecules with very promising results. Besides their introduction in screening programs, further studies are now needed in the acute setting, beyond or in association with troponin levels. This will help to better discriminate the real occurrence of an ACS in many patients accessing the emergency department for chest pain.
2020
Inglese
Piccioni, A., Valletta, F., Zanza, C., Esperide, A., Franceschi, F., Novel biomarkers to assess the risk for acute coronary syndrome: beyond troponins, <<INTERNAL AND EMERGENCY MEDICINE>>, 2020; 15 (7): 1193-1199. [doi:10.1007/s11739-020-02422-z] [https://hdl.handle.net/10807/231889]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10807/231889
Citazioni
  • ???jsp.display-item.citation.pmc??? 3
  • Scopus 3
  • ???jsp.display-item.citation.isi??? 4
social impact